Disentangling biological signaling networks bydynamic coupling of signaling lipids tomodifying enzymes

Advances in Biological Regulation

Volumn 54, Issue 1, 2014, Pages 25-38

  Blind, Raymond D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROIDOGENIC FACTOR 1;

ANIMAL; HUMAN; LIPID METABOLISM; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LIPID METABOLISM; SIGNAL TRANSDUCTION; STEROIDOGENIC FACTOR 1;

EID: 84893416647     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2013.09.015     Document Type: Review

References (96)

1. Antiqueira L., Janga S.C., Costa Lda F. Extensive cross-talk and global regulators identified from an analysis of the integrated transcriptional and signaling network in Escherichia coli. Mol BioSys 2012, 8:3028-3035.
2. Baker P.R., Lin Y., Schopfer F.J., Woodcock S.R., Groeger A.L., Batthyany C., et al. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. JBiol Chem 2005, 280:42464-42475.
3. Bankaitis V.A., Ile K.E., Nile A.H., Ren J., Ghosh R., Schaaf G. Thoughts on Sec14-like nanoreactors and phosphoinositide signaling. Adv Biol Reg 2012, 52:115-121.
4. Barlow C.A., Laishram R.S., Anderson R.A. Nuclear phosphoinositides: a signaling enigma wrapped in a compartmental conundrum. Trends Cell Biol 2010, 20:25-35.
5. Bassi C., Ho J., Srikumar T., Dowling R.J., Gorrini C., Miller S.J., et al. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Sci 2013, 341:395-399.
6. Bhabak K.P., Proksch D., Redmer S., Arenz C. Novel fluorescent ceramide derivatives for probing ceramidase substrate specificity. Bioorgan Med Chem 2012, 20:6154-6161.
7. Bhalla U.S., Iyengar R. Emergent properties of networks of biological signaling pathways. Sci 1999, 283:381-387.
8. Bhalla U.S., Ram P.T., Iyengar R. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Sci 2002, 297:1018-1023.
9. Blind R.D., Suzawa M., Ingraham H.A. Direct modification and activation of a nuclear receptor-PIP(2) complex by the inositol lipid kinase IPMK. Sci Sig 2012, 5:ra44.
10. Boronenkov I.V., Loijens J.C., Umeda M., Anderson R.A. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell 1998, 9:3547-3560.
11. Buchler N.E., Cross F.R. Protein sequestration generates a flexible ultrasensitive response in a genetic network. Mol Sys Biol 2009, 5:272.
12. Burris T.P., Solt L.A., Wang Y., Crumbley C., Banerjee S., Griffett K., et al. Nuclear receptors and their selective pharmacologic modulators. Pharmacol Rev 2013, 65:710-778.
13. Cai K., Sewer M.B. cAMP-stimulated transcription of DGKtheta requires steroidogenic factor 1 and sterol regulatory element binding protein 1. JLipid Res 2013, 54:2121-2132.
14. Cai L., Dalal C.K., Elowitz M.B. Frequency-modulated nuclear localization bursts coordinate gene regulation. Nat 2008, 455:485-490.
15. Chang S.C., Miller A.L., Feng Y., Wente S.R., Majerus P.W. The human homolog of the rat inositol phosphate multikinase is an inositol 1,3,4,6-tetrakisphosphate 5-kinase. JBiol Chem 2002, 277:43836-43843.
16. Cockcroft S. Phosphatidylinositol transfer proteins: requirements in phospholipase C signaling and in regulated exocytosis. Febs Lett 1997, 410:44-48.
17. Cockcroft S. The diverse functions of phosphatidylinositol transfer proteins. Curr Top Microbiol Immunol 2012, 362:185-208.
18. Cockcroft S., Carvou N. Biochemical and biological functions of class I phosphatidylinositol transfer proteins. Biochimica et biophysica acta 2007, 1771:677-691.
19. Cohen P., Cohen P.T. Protein phosphatases come of age. JBiol Chem 1989, 264:21435-21438.
20. Dammer E.B., Leon A., Sewer M.B. Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3',5'-monophosphate-dependent cytochrome P450c17 transcription rate. Mol Endocrinol 2007, 21:415-438.
21. Diehn M., Eisen M.B., Botstein D., Brown P.O. Large-scale identification of secreted and membrane-associated gene products using DNA microarrays. Nat Genet 2000, 25:58-62.
22. Dutkowski J., Kramer M., Surma M.A., Balakrishnan R., Cherry J.M., Krogan N.J., et al. Agene ontology inferred from molecular networks. Nat Biotechnol 2013, 31:38-45.
23. Follo M.Y., Faenza I., Fiume R., Ramazzotti G., McCubrey J.A., Martelli A.M., et al. Revisiting nuclear phospholipase C signalling in MDS. Adv Biol Reg 2012, 52:2-6.
24. Follo M.Y., Marmiroli S., Faenza I., Fiume R., Ramazzotti G., Martelli A.M., et al. Nuclear phospholipase C beta1 signaling, epigenetics and treatments in MDS. Adv Biol Reg 2013, 53:2-7.
25. Fritsche-Guenther R., Witzel F., Sieber A., Herr R., Schmidt N., Braun S., et al. Strong negative feedback from Erk to Raf confers robustness to MAPK signalling. Mol Sys Biol 2011, 7:489.
26. Ganesan A., Zhang J. How cells process information: quantification of spatiotemporal signaling dynamics. Protein Sci A Pub Prot Soc 2012, 21:918-928.
27. Good M., Tang G., Singleton J., Remenyi A., Lim W.A. The Ste5 scaffold directs mating signaling by catalytically unlocking the Fus3 MAP kinase for activation. Cell 2009, 136:1085-1097.
28. Good M.C., Zalatan J.G., Lim W.A. Scaffold proteins: hubs for controlling the flow of cellular information. Sci 2011, 332:680-686.
29. Granek J.A., Kayikci O., Magwene P.M. Pleiotropic signaling pathways orchestrate yeast development. Curr Opin Microbiol 2011, 14:676-681.
30. Grecco H.E., Schmick M., Bastiaens P.I. Signaling from the living plasma membrane. Cell 2011, 144:897-909.
31. Guruharsha K.G., Kankel M.W., Artavanis-Tsakonas S. The Notch signalling system: recent insights into the complexity of a conserved pathway. Nature reviews. Gene 2012, 13:654-666.
32. Hammond G.R., Schiavo G., Irvine R.F. Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2). Biochem J 2009, 422:23-35.
33. Helikar T., Konvalina J., Heidel J., Rogers J.A. Emergent decision-making in biological signal transduction networks. Proc Natl Acad Sci U S A 2008, 105:1913-1918.
34. Huang Y., Zhang H., Shao Z., O'Hara K.A., Kopilas M.A., Yu L., et al. Suppression of endothelin-1-induced cardiac myocyte hypertrophy by PPAR agonists: role of diacylglycerol kinase zeta. Cardiovasc Res 2011, 90:267-275.
35. Hunt A.N. Dynamic lipidomics of the nucleus. JCell Biochem 2006, 97:244-251.
36. Irvine R.F. Nuclear lipid signalling. Nature reviews. Mol Cell Biol 2003, 4:349-360.
37. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nat 1990, 347:645-650.
38. Kapp G.T., Liu S., Stein A., Wong D.T., Remenyi A., Yeh B.J., et al. Control of protein signaling using a computationally designed GTPase/GEF orthogonal pair. Proc Natl Acad Sci U S A 2012, 109:5277-5282.
39. Keune W.J., Jones D.R., Divecha N. PtdIns5P and Pin1 in oxidative stress signaling. Adv Biol Reg 2013, 53:179-189.
40. Kholodenko B.N., Hancock J.F., Kolch W. Signalling ballet in space and time. Nature reviews. Mol Cell Biol 2010, 11:414-426.
41. Kiel C., Serrano L. Challenges ahead in signal transduction: MAPK as an example. Curr Opin Biotechnol 2012, 23:305-314.
42. Kiel C., Serrano L. Structural data in synthetic biology approaches for studying general design principles of cellular signaling networks. Struct 2012, 20:1806-1813.
43. Krylova I.N., Sablin E.P., Moore J., Xu R.X., Waitt G.M., MacKay J.A., et al. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 2005, 120:343-355.
44. Ku C.J., Wang Y., Weiner O.D., Altschuler S.J., Wu L.F. Network crosstalk dynamically changes during neutrophil polarization. Cell 2012, 149:1073-1083.
45. Kulkarni M.M., Perrimon N. Analyzing the structure, function and information flow in signaling networks using quantitative cellular signatures. Handbook of systems biology concepts and insights 2013, 89-113. Elsevier.
46. Kurosaki T. Regulation of B-cell signal transduction by adaptor proteins. Nature reviews. Immunol 2002, 2:354-363.
47. Lee J.M., Lee Y.K., Mamrosh J.L., Busby S.A., Griffin P.R., Pathak M.C., et al. Anuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nat 2011, 474:506-510.
48. Lerner R.S., Seiser R.M., Zheng T., Lager P.J., Reedy M.C., Keene J.D., et al. Partitioning and translation of mRNAs encoding soluble proteins on membrane-bound ribosomes. RNA 2003, 9:1123-1137.
49. Lev S. Nonvesicular lipid transfer from the endoplasmic reticulum. Cold Spring Harbor Persp Biol 2012, 4.
50. Levy S.F., Siegal M.L. The robustness continuum. Adv Exp Med Biol 2012, 751:431-452.
51. Li D., Urs A.N., Allegood J., Leon A., Merrill A.H., Sewer M.B. Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17. Mol Cell Biol 2007, 27:6669-6685.
52. Li W., Laishram R.S., Ji Z., Barlow C.A., Tian B., Anderson R.A. Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIalpha and PKCdelta signaling. Mol Cell 2012, 45:25-37.
53. Li Y., Choi M., Cavey G., Daugherty J., Suino K., Kovach A., et al. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol Cell 2005, 17:491-502.
54. Lindsay Y., McCoull D., Davidson L., Leslie N.R., Fairservice A., Gray A., et al. Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. JCell Sci 2006, 119:5160-5168.
55. Lucki N.C., Li D., Bandyopadhyay S., Wang E., Merrill A.H., Sewer M.B. Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor. Mol Cell Biol 2012, 32:4419-4431.
56. Lucki N.C., Sewer M.B. Multiple roles for sphingolipids in steroid hormone biosynthesis. Sub Cell Biochem 2008, 49:387-412.
57. Lucki N.C., Sewer M.B. Nuclear sphingolipid metabolism. Annu Rev Physiol 2012, 74:131-151.
58. Lund J., Borud B., Mellgren G., Aesoy R., Hoang T., Jacob A.L., et al. Differential regulation of SF-1-cofactor interactions. Endocr Res 2002, 28:505-513.
59. Macbeth M.R., Schubert H.L., Vandemark A.P., Lingam A.T., Hill C.P., Bass B.L. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Sci 2005, 309:1534-1539.
60. Maehama T., Dixon J.E. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol 1999, 9:125-128.
61. Maraldi N.M., Cocco L., Capitani S., Mazzotti G., Barnabei O., Manzoli F.A. Lipid-dependent nuclear signalling: morphological and functional features. Adv Enzyme Reg 1994, 34:129-143.
62. Mellman D.L., Gonzales M.L., Song C., Barlow C.A., Wang P., Kendziorski C., et al. APtdIns4,5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs. Nat 2008, 451:1013-1017.
63. Morohashi K., Hatano O., Nomura M., Takayama K., Hara M., Yoshii H., et al. Function and distribution of a steroidogenic cell-specific transcription factor, Ad4BP. JSteroid Biochem Mol Biol 1995, 53:81-88.
64. Musille P.M., Kohn J.A., Ortlund E.A. Phospholipid-driven gene regulation. Febs Lett 2013, 587:1238-1246.
65. Musille P.M., Pathak M.C., Lauer J.L., Hudson W.H., Griffin P.R., Ortlund E.A. Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation. Nat Struct Mol Biol 2012, 19:532-537. S531-S532.
66. Natarajan M., Lin K.M., Hsueh R.C., Sternweis P.C., Ranganathan R. Aglobal analysis of cross-talk in a mammalian cellular signalling network. Nat Cell Biol 2006, 8:571-580.
67. Omura T., Morohashi K. Gene regulation of steroidogenesis. JSteroid Biochem Mol Biol 1995, 53:19-25.
68. Ortlund E.A., Lee Y., Solomon I.H., Hager J.M., Safi R., Choi Y., et al. Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP. Nat Struct Mol Biol 2005, 12:357-363.
69. Pandey N.R., Renwick J., Misquith A., Sokoll K., Sparks D.L. Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion. Biochem 2008, 47:1579-1587.
70. Phillips S.E., Vincent P., Rizzieri K.E., Schaaf G., Bankaitis V.A., Gaucher E.A. The diverse biological functions of phosphatidylinositol transfer proteins in eukaryotes. Crit Rev Biochem Mol Biol 2006, 41:21-49.
71. Poyatos J.F. On the search for design principles in biological systems. Adv Exp Med Biol 2012, 751:183-193.
72. Purvis J.E., Lahav G. Encoding and decoding cellular information through signaling dynamics. Cell 2013, 152:945-956.
73. Raben D.M., Tu-Sekine B. Nuclear diacylglycerol kinases: regulation and roles. Front Biosci A J Virt Lib 2008, 13:590-597.
74. Rajakulendran T., Sahmi M., Lefrancois M., Sicheri F., Therrien M. Adimerization-dependent mechanism drives RAF catalytic activation. Nat 2009, 461:542-545.
75. Reid D.W., Nicchitta C.V. Primary role for endoplasmic reticulum-bound ribosomes in cellular translation identified by ribosome profiling. JBiol Chem 2012, 287:5518-5527.
76. Resnick A.C., Snowman A.M., Kang B.N., Hurt K.J., Snyder S.H., Saiardi A. Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity. Proc Natl Acad Sci U S A 2005, 102:12783-12788.
77. Rocks O., Peyker A., Kahms M., Verveer P.J., Koerner C., Lumbierres M., et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Sci 2005, 307:1746-1752.
78. Rose H.G., Frenster J.H. Composition and metabolism of lipids within repressed and active chromatin of interphase lymphocytes. Biochimica et biophysica acta 1965, 106:577-591.
79. Sablin E.P., Blind R.D., Krylova I.N., Ingraham J.G., Cai F., Williams J.D., et al. Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. Mol Endocrinol 2009, 23:25-34.
80. Sablin E.P., Krylova I.N., Fletterick R.J., Ingraham H.A. Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol Cell 2003, 11:1575-1585.
81. Schaaf G., Ortlund E.A., Tyeryar K.R., Mousley C.J., Ile K.E., Garrett T.A., et al. Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the sec14 superfamily. Mol Cell 2008, 29:191-206.
82. Schramp M., Hedman A., Li W., Tan X., Anderson R. PIP kinases from the cell membrane to the nucleus. Sub Cell Biochem 2012, 58:25-59.
83. Scott J.D., Pawson T. Cell signaling in space and time: where proteins come together and when they're apart. Sci 2009, 326:1220-1224.
84. Steinacher A., Soyer O.S. Evolutionary principles underlying structure and response dynamics of cellular networks. Adv Exp Med Biol 2012, 751:225-247.
85. Telesco S.E., Radhakrishnan R. Structural systems biology and multiscale signaling models. Ann Biomed Eng 2012, 40:2295-2306.
86. Tsukahara T., Tsukahara R., Fujiwara Y., Yue J., Cheng Y., Guo H., et al. Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid. Mol Cell 2010, 39:421-432.
87. Urs A.N., Dammer E., Kelly S., Wang E., Merrill A.H., Sewer M.B. Steroidogenic factor-1 is a sphingolipid binding protein. Mol Cell Endocrinol 2007, 265-266:174-178.
88. Urs A.N., Dammer E., Sewer M.B. Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. Endocrinol 2006, 147:5249-5258.
89. van Wageningen S., Kemmeren P., Lijnzaad P., Margaritis T., Benschop J.J., de Castro I.J., et al. Functional overlap and regulatory links shape genetic interactions between signaling pathways. Cell 2010, 143:991-1004.
90. Vann L.R., Wooding F.B., Irvine R.F., Divecha N. Metabolism and possible compartmentalization of inositol lipids in isolated rat-liver nuclei. Biochem J 1997, 327(Pt 2):569-576.
91. von Kriegsheim A., Baiocchi D., Birtwistle M., Sumpton D., Bienvenut W., Morrice N., et al. Cell fate decisions are specified by the dynamic ERK interactome. Nat Cell Biol 2009, 11:1458-1464.
92. Wahli W., Michalik L. PPARs at the crossroads of lipid signaling and inflammation. TEM 2012, 23:351-363.
93. Watson P.J., Fairall L., Santos G.M., Schwabe J.W. Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nat 2012, 481:335-340.
94. Weng G., Bhalla U.S., Iyengar R. Complexity in biological signaling systems. Sci 1999, 284:92-96.
95. Whitmarsh A.J., Cavanagh J., Tournier C., Yasuda J., Davis R.J. Amammalian scaffold complex that selectively mediates MAP kinase activation. Sci 1998, 281:1671-1674.
96. Yu Y., Yoon S.O., Poulogiannis G., Yang Q., Ma X.M., Villen J., et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Sci 2011, 332:1322-1326.